NIGERIA – Medsaf Company, Africa’s leading pharmaceutical technology provider, has appointed three new executives to strengthen its management team and expand business growth.
The company has named Mr. Kenny Oriola as the new Chief Operations Officer and Mr. Obinna Ajeroh as the Business Development Director to grow its senior management team.
In addition, the company has appointed Mr. Joao Pinheiro as the Chief Technology Officer to join Medsaf with immediate effect.
The top online pharmaceutical marketplace is increasing the quality and access of medication dispensed in Africa through innovative technology and financing facilities.
Moreover, it provides patients with precise prices on their medication needs immediately through a simple 7-layer quality control vetting process.
“Medsaf is strengthening the management team by expanding the company’s executive capabilities which is in line with its ambitious growth and expansion plan for 2022,” highlighted Medsaf in a statement.
Pinheiro has more than 25 years of experience building and managing tech projects including his former role as Lead Developer for Rocket Internet where he worked on early iterations of Jumia Africa.
As a co-founder, he is returning to Medsaf with his experience spanning across many industries including cybersecurity, marketplaces and warehousing.
Co-founder & Chief Executive Officer of Medsaf, Vivian Nwakah assured the new appointments that the firm has positioned itself as a solution-provider to one of the most challenging issues in the healthcare space in Africa, gaining access to genuine and authentic medication.
She further said that Medsaf was a new breed of startups on the edge of fintech and healthtech.
“Medsaf supports a fundamental human right by addressing a significant public health crisis through increasing access for all Africans to affordable and quality medication,” reaffirmed Co-founder Vivian
The enterprise combats the spread of fake medicines by increasing access, affordability and quality of medications dispensed to Africans through proprietary technology, data analytics and quality control.
“In pursuit of this strategy, Medsaf has seen tremendous growth since it launched in 2017 with an average yearly growth rate of 150% and over 500% growth rate in 2021 alone,” outlined the statement.
The enterprise’s current growth trajectory is backed by international funders and donors with an aim to impact the public health sector in the Africa.
The company has raised US$2.7 million since inception from investors such as Lateral Capital, Samurai Incubate, Seedstars, Musha Ventures, Spark, Yvonne Wassenaar, Proparco and Stonks.
Medsaf presently offers a range of products and services designed to improve patient care and has regional growth plans to expand beyond Nigeria into Kenya as well as West Africa.
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE
